Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Mole101on Feb 15, 2022 5:19pm
159 Views
Post# 34431687

RE:.015?

RE:.015?

In my opinion it's just games , There is still an NR for submission coming up , could be this week and of course the wait for FDA approval. Shares to be picked , but the big hitters want them cheep ..

House 001
Anonymous
Bought $315,656
Volume 781,500
Average $0.404
Sold $273,293
Volume 686,500
Average $0.398
Net $42,363
Volume 95,000
 
House 085
Scotia
Bought $145,047
Volume 373,625
Average $0.388
Sold $113,591
Volume 283,268
Average $0.401
Net $31,456
Volume 90,357
 
House 080
National Bank
Bought $46,413
Volume 118,365
Average $0.392
Sold $28,059
Volume 69,536
Average $0.404
Net $18,354
Volume 48,829
 
House 002
RBC
Bought $33,002
Volume 84,411
Average $0.391
Sold $58,686
Volume 145,851
Average $0.402
Net $-25,684
Volume -61,440
 
House 079
CIBC
Bought $91,806
Volume 230,200
Average $0.399
Sold $119,194
Volume 299,600
Average $0.398
Net $-27,388
Volume -69,400
 
House 033
Canaccord
Bought $14,757
Volume 36,500
Average $0.404
Sold $47,734
Volume 122,500
Average $0.390
Net $-32,977
Volume -86,000
 

YoungBaklava wrote: For such long awaited news about finally reaching the last FDA testing stages, and in comparison to how much THRM was at(.42) when Fia just announced a timeline to announce this news, .015 as a gain and such a downfall of a day in terms of growth makes me wonder if the latest news of pcr test elimination going throughout all news outlets provided many with misinformation that testing completely would disappear for travellers or maybe many don't know that THRM is an antigen test not pcr or they simply lack that they're different test lmao???
Do any of you have any idea to why the gain today slowly evaporated aswell as buys? Aside, atleast any growth is a good sign I suppose!

 

<< Previous
Bullboard Posts
Next >>